注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Imunon Inc(原名:Celsion Corporation),是一家临床阶段的生物技术公司。该公司专注于通过临床试验推进一系列治疗方法,包括基于脱氧核糖核酸(DNA)的免疫疗法、疫苗和定向化学疗法。其主要临床项目GEN-1,一种基于DNA的免疫疗法,用于晚期卵巢癌的局部治疗。GEN-1的作用是指导身体在肿瘤部位产生抗癌分子,例如白细胞介素12和干扰素γ。公司拥有两项平台技术:TheraPlas平台用于开发基于核酸的免疫疗法和疫苗,以及其他抗癌DNA或核糖核酸(RNA)疗法,其PLACCINE平台用于开发用于感染性疾病的核酸疫苗和癌症。其平台技术基于独立于病毒载体或装置的新型合成递送系统的核酸递送。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Michael H. Tardugno | 71 | 2007 | Executive Chairman |
Donald P. Braun | 74 | 2015 | Independent Director |
Wafik El-Deiry | - | - | Member of Advisory Board |
Frederick J. Fritz | 73 | 2011 | Independent Director |
Mark W. Dewhirst | - | - | Member of Advisory Board |
Michael E. Weinblatt | - | - | Member of Advisory Board |
David Cheresh | - | - | Member of Advisory Board |
Jerry Glickson | - | - | Member of Advisory Board |
Britt A. Glaunsinger | - | 2021 | Member of the Advisory Board |
Luke D. Handke | - | 2021 | Member of Vaccine Advisory Board |
Patrick Ott | - | 2023 | Member of Scientific Advisory Board |
Peter Corry | - | - | Member of Advisory Board |
Stacy R. Lindborg | 54 | 2021 | Independent Director |
Xinzhen Yang | - | 2021 | Member of the Advisory Board |
Christine A. Pellizzari | 56 | 2021 | Independent Director |
Dan H. Barouch | - | 2021 | Member of Vaccine Advisory Board |
Sachet A. Shukla | - | 2023 | Member of Scientific Advisory Board |
James E. Dentzer | 57 | 2022 | Independent Director |
John W. Shiver | - | - | Member of Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核